Does reperfusion injury still cause significant mortality after lung transplantation?

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 3, 2009, Pages 688-694

  Ailawadi, Gorav ^a   Lau, Christine L ^a   Smith, Philip W ^a   Swenson, Brian R ^a   Hennessy, Sara A ^a   Kuhn, Courtney J ^a   Fedoruk, Lynn M ^a   Kozower, Benjamin D ^a   Kron, Irving L ^a   Jones, David R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; PREDNISONE; PROSTACYCLIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADULT; AIRWAY PRESSURE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; RISK FACTOR; TREATMENT OUTCOME;

FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 60949111055     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.11.007     Document Type: Article

References (31)

1. Trulock E.P., Christie J.D., Edwards L.B., Boucek M.M., Aurora P., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 782-795
2. Cottini S.R., Lerch N., De Perrot M., Treggiari M.M., Spiliopoulos A., Nicod L., et al. Risk factors for reperfusion injury after lung transplantation. Intensive Care Med 32 (2006) 557-563
3. Scientific Registry of Transplant Recipients. Available at: www.ustransplant.org. Accessed April 21, 2008.
4. Fiser S.M., Kron I.L., McLendon Long S., Kaza A.K., Kern J.A., and Tribble C.G. Early intervention after severe oxygenation index elevation improves survival following lung transplantation. J Heart Lung Transplant 20 (2001) 631-636
5. Christie J.D., Carby M., Bag R., Corris P., Hertz M., and Weill D. ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 (2005) 1454-1459
6. Dellinger R.P., Zimmerman J.L., Taylor R.W., Straube R.C., Hauser D.L., Criner G.J., et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomixzed phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 26 (1998) 15-23
7. Whitson B.A., Nath D.S., Johnson A.C., Walker A.R., Prekker M.E., Radosevich D.M., et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 131 (2006) 73-80
8. Burdine J., Hertz M.I., Snover D.C., and Bolman III R.M. Heart-lung and lung transplantation: perioperative pulmonary dysfunction. Transplant Proc 23 (1991) 1176-1177
9. Burton C.M., Iversen M., Milman N., Zemtsovski M., Carlsen J., Steinbrüchel D., et al. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 31 (2007) 75-82
10. Vainikka T., Heikkilä L., Kukkonen S., Toivonen H., Verkkala K., and Mattila S. Donor lung pretreatment with prostaglandin E(1) does not improve lung graft preservation. Eur Surg Res 31 (1999) 429-436
11. Kukkonen S., Heikkilä L.J., Verkkala K., Mattila S.P., and Toivonen H. Prostaglandin E1 or prostacyclin in Euro-Collins solution fails to improve lung preservation. Ann Thorac Surg 60 (1995) 1617-1622
12. De Perrot M., Fischer S., Liu M., Jin R., Bai X.H., Waddell T.K., et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation 72 (2001) 1505-1512
13. Chiang C.H., Wu K., Yu C.P., Yan H.C., Perng W.C., and Wu C.P. Hypothermia and prostaglandin E(1) produce synergistic attenuation of ischemia-reperfusion lung injury. Am J Respir Crit Care Med 160 (1999) 1319-1323
14. Keshavjee S.H., Yamazaki F., Cardoso P.F., McRitchie D.I., Patterson G.A., and Cooper J.D. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg 98 (1989) 529-534
15. Fischer S., Matte-Martyn A., De Perrot M., Waddell T.K., Sekine Y., Hutcheon M., et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 121 (2001) 594-596
16. Oto T., Griffiths A.P., Rosenfeldt F., Levvey B.J., Williams T.J., and Snell G.I. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 82 (2006) 1842-1848
17. Aziz T.M., Pillay T.M., Corris P.A., Forty J., Hilton C.J., Hasan A., et al. Perfadex for clinical lung procurement: is it an advance?. Ann Thorac Surg 75 (2003) 990-995
18. Nath D.S., Walter A.R., Johnson A.C., Radosevich D.M., Prekker M.E., Herrington C.S., et al. Does Perfadex affect outcomes in clinical lung transplantation?. J Heart Lung Transplant 24 (2005) 2243-2248
19. Aoe M., Okabayashi K., Cooper J.D., and Patterson G.A. Hyperinflation of canine lung allografts during storage increases reperfusion pulmonary edema. J Thorac Cardiovasc Surg 112 (1996) 94-102
20. Halldorsson A., Kronon M., Allen B.S., Bolling K.S., Wang T., Rahman S., et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. J Thorac Cardiovasc Surg 115 (1998) 415-424
21. Fiser S.M., Kron I.L., Long S.M., Kaza A.K., Kern J.A., Cassada D.C., et al. Controlled perfusion decreases reperfusion injury after high-flow reperfusion. J Heart Lung Transplant 21 (2002) 687-691
22. Pierre A.F., DeCampos K.N., Liu M., Edwards V., Cutz E., Slutsky A.S., et al. Rapid reperfusion causes stress failure in ischemic rat lungs. J Thorac Cardiovasc Surg 116 (1998) 932-942
23. Ailawadi G., Smith P.W., Oka T., Wang H., Kozower B.D., Daniel T.M., et al. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. J Thorac Cardiovasc Surg 135 (2008) 594-602
24. Eisner M.D., Thompson T., Hudson L.D., Luce J.M., Hayden D., Schoenfeld D., et al. Acute Respiratory Distress Syndrome Network. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 164 (2001) 231-236
25. Date H., Triantafillou A.N., Trulock E.P., Pohl M.S., Cooper J.D., and Patterson G.A. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 111 (1996) 913-919
26. Fiser S.M., Cope J.T., Kron I.L., Kaza A.K., Long S.M., Kern J.A., et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 121 (2001) 981-982
27. Meyers B.F., Sundt III T.M., Henry S., Trulock E.P., Guthrie T., Cooper J.D., et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 120 (2000) 20-26
28. Meyers B.F., de la Morena M., Sweet S.C., Trulock E.P., Guthrie T.J., Mendeloff E.N., et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 129 (2005) 1421-1429
29. Carter Y.M., and Davis R.D. Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 27 (2006) 501-507
30. Oto T., Levvey B.J., and Snell G.I. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system. J Heart Lung Transplant 26 (2007) 431-436
31. Christie J., Keshavjee S., Orens J., Arcasoy S., DePerrot M., Barr M., et al. ISHLT Working Group on PGD. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system. J Heart Lung Transplant 27 (2008) 138